BIOMEDMICROFLUIDICS

Modelling and Optimization of Microfluidic Devices for Biomedical Applications

 Coordinatore ZILINSKA UNIVERZITA V ZILINE 

 Organization address address: UNIVERZITHA 821 5/1
city: ZILINA
postcode: 1026

contact info
Titolo: Dr.
Nome: Emil
Cognome: Krsak
Email: send email
Telefono: 421415000000

 Nazionalità Coordinatore Slovakia [SK]
 Totale costo 100˙000 €
 EC contributo 100˙000 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2011-CIG
 Funding Scheme MC-CIG
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-04-01   -   2016-03-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ZILINSKA UNIVERZITA V ZILINE

 Organization address address: UNIVERZITHA 821 5/1
city: ZILINA
postcode: 1026

contact info
Titolo: Dr.
Nome: Emil
Cognome: Krsak
Email: send email
Telefono: 421415000000

SK (ZILINA) coordinator 100˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

cells    optimization    microfluidic    framework    efficiency    tumor    patients    techniques    isolated    simulation    rigorous    disease    ctcs    justified    blood    mathematically   

 Obiettivo del progetto (Objective)

'Circulating tumor cells (CTCs) are isolated tumor cells disseminated from the site of disease in metastatic or primary cancers, including breast, prostate, and lung cancer. CTCs can be identified and counted in the peripheral blood of patients. The biological analysis of CTCs using lab-on-chip technologies effectively diagnose the disease, determine personalized therapies, and adjust treatments in real time. This significantly increases the survival chance of the patients. Because of their rare occurrence, a few CTCs per 1 mL of blood, the CTCs must be isolated from the blood sample. Recent developments of microfluidic devices made a significant breakthrough in the detection and filtration of CTCs from blood.

The aim of the project is to incorporate rigorous optimization techniques in the development of such devices. In the design process of currently manufactured devices, the focus has not been put on the performance optimization. The use of mathematically justified optimization techniques offers huge potential for increasing the efficiency.

A computer tool for simulation of complex processes inside microfluidic devices will be developed. A novel capture mechanism based on local affinity interactions will be elaborated. An optimization framework will be established and implemented in the software. With this framework, new devices with higher efficiency will be designed.

During the designing process, different concepts will be optimized, e.g. geometry, blood flow velocities, external magnetic fields manipulating ferromagnetic parts of the device, and other. The optimization will be carried out in a rigorous way by applying iterative optimization techniques, which is a novel element in the development of microfluidic devices.

The underlying physical models will be properly calibrated and validated, and the simulation and the optimization methods will be mathematically justified.'

Altri progetti dello stesso programma (FP7-PEOPLE)

GENFUEL (2014)

Addressing Fundamental Challenges in the Design of new generation fuels

Read More  

SCALE (2013)

Scalable Switching Architectures for Next-Generation Data Center Networks

Read More  

PEPTIDE DENDRIMERS (2011)

Peptide Dendrimers - A Chemical Platform for Functional Diversity

Read More